Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2015

Aug 11, 2015

31565_dirs_2015-08-11_e59b4012-c029-4b70-a200-5f60ee15c7f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-07-21

Reporting Person: Fusco David (EVP, Global Human Resources)